Virtual Symposium (Expired): Evolving Therapeutic Paradigms for the Management of Hyperkalemia

Management of patients who are at chronic risk for hyperkalemia frequently include dietary modifications and/or discontinuation of specific medications that confer renal and/or cardiac protection. Weighing the risk of hyperkalemia against the risk of discontinuing reno- and cardio-protective therapies can present a paradox to clinicians treating hyperkalemia. Although the short-term management of hyperkalemia can be very effective, the utility of current strategies to manage hyperkalemia is limited, with no long-term outcome data to guide in the management of this condition. New therapies to manage hyperkalemia are currently available and under development that may provide safer, more consistent management.

This activity will review the most up-to-date clinical evidence on these new and potential therapies for the long-term management of hyperkalemia to improve guideline adherence and help clinicians move toward providing appropriate management for hyperkalemic patients with CKD, diabetes mellitus (DM), and/or HF by assessing risk profiles and customizing regimens based on individual patient needs.

Hyperkalemia Management in Heart Failure: A Clinical Conundrum

Faculty: JoAnn Lindenfeld, MD

The Management of Hyperkalemia in Patients: Diabetic Kidney Disease

Faculty: Robert D. Toto, MD

What's New in Hyperkalemia: Focus on Clinical Trials

Faculty: Rajiv Agarwal, MD

Case Discussion: Potassium Binding Agents in Patients with Hyperkalemia in Clinical Practice - Lessons Learned/Best Practices

Faculty: George L. Bakris, MD

Presenter: All Faculty

Audience Q&A and Closing Remarks

Faculty: George L. Bakris, MD

Presenter: All Faculty